Follow
Veronika Jaeger
Veronika Jaeger
University of Münster, Institute for Epidemiology und Social Medicine
Verified email at ukmuenster.de
Title
Cited by
Cited by
Year
Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study
VK Jaeger, EG Wirz, Y Allanore, P Rossbach, G Riemekasten, E Hachulla, ...
PloS one 11 (10), e0163894, 2016
1652016
High colonization rates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in Swiss travellers to South Asia-a prospective observational multicentre cohort …
E Kuenzli, VK Jaeger, R Frei, A Neumayr, S DeCrom, S Haller, J Blum, ...
BMC infectious diseases 14, 528-528, 2014
1442014
Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow …
E Croce, C Hatz, EF Jonker, LG Visser, VK Jaeger, S Bühler
Vaccine 35 (9), 1216-1226, 2017
1372017
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a …
G Valentini, M Iudici, UA Walker, VK Jaeger, M Baron, P Carreira, ...
Annals of the Rheumatic Diseases 76 (1), 270-276, 2017
1362017
Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database
EG Wirz, VK Jaeger, Y Allanore, G Riemekasten, E Hachulla, O Distler, ...
Annals of the rheumatic diseases, annrheumdis-2015-207271, 2015
732015
Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group
VK Jaeger, O Distler, B Maurer, L Czirják, V Lóránd, G Valentini, S Vettori, ...
Rheumatology, kex182, 2017
672017
Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma …
W Wu, S Jordan, N Graf, J de Oliveira Pena, J Curram, Y Allanore, ...
Annals of the rheumatic diseases 78 (5), 648-656, 2019
652019
Immune reconstitution after allogeneic hematopoietic stem cell transplantation and association with occurrence and outcome of invasive aspergillosis
C Stuehler, E Kuenzli, VK Jaeger, V Baettig, F Ferracin, Z Rajacic, ...
The Journal of infectious diseases 212 (6), 959-967, 2015
652015
Safety of vaccinations in patients with cryopyrin-associated periodic syndromes: a prospective registry based study
VK Jaeger, HM Hoffman, T van der Poll, H Tilson, J Seibert, A Speziale, ...
Rheumatology 56 (9), 1484-1491, 2017
532017
A profile of travelers—an analysis from a large Swiss travel clinic
S Bühler, R Rüegg, R Steffen, C Hatz, VK Jaeger
Journal of travel medicine 21 (5), 324-331, 2014
412014
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis
M Becker, N Graf, R Sauter, Y Allanore, J Curram, CP Denton, D Khanna, ...
Annals of the Rheumatic Diseases, annrheumdis-2019-215145, 2019
352019
The elderly, the young and the pregnant traveler--A retrospective data analysis from a large Swiss Travel Center with a special focus on malaria prophylaxis and yellow fever …
VK Jaeger, N Tschudi, R Rüegg, C Hatz, S Bühler
Travel medicine and infectious disease 13 (6), 475-484, 2015
332015
Single-Dose Hepatitis A Immunization: 7.5-Year Observational Pilot Study in Nicaraguan Children to Assess Protective Effectiveness and Humoral Immune Memory Response
O Mayorga, S Bühler, VK Jaeger, S Bally, C Hatz, G Frösner, U Protzer, ...
The Journal of infectious diseases 214 (10), 1498-1506, 2016
312016
Rituximab done: what’s next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in …
UA Walker, VK Jaeger, K Chatzidionysiou, ML Hetland, EM Hauge, ...
Rheumatology 55 (2), 230-236, 2016
312016
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the …
G Valentini, D Huscher, A Riccardi, S Fasano, R Irace, V Messiniti, ...
Annals of the Rheumatic Diseases 78 (11), 1576-1582, 2019
292019
Disease activity dynamics in rheumatoid arthritis: patients’ self-assessment of disease activity via WebApp
UA Walker, RB Mueller, VK Jaeger, R Theiler, A Forster, P Dufner, F Ganz, ...
Rheumatology, 2017
272017
Peripheral neuropathy in antineutrophil cytoplasmic antibody-associated vasculitides: Insights from the DCVAS study
A Bischof, VK Jaeger, RDM Hadden, RA Luqmani, AK Pröbstel, ...
Neurology-Neuroimmunology Neuroinflammation 6 (6), e615, 2019
252019
Autopsy versus clinical findings in patients with systemic sclerosis in a case series from patients of the EUSTAR database
B Sandmeier, VK Jäger, G Nagy, PE Carreira, A Tzankov, ...
Clin Exp Rheumatol 33 (4 Suppl 91), S75-9, 2015
242015
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real …
J Blagojevic, G Abignano, J Avouac, L Cometi, M Frerix, ...
Clinical rheumatology 39 (1), 27-36, 2020
232020
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study
VK Jaeger, M Tikly, D Xu, E Siegert, E Hachulla, P Airò, G Valentini, ...
Rheumatology 59 (7), 1684-1694, 2020
222020
The system can't perform the operation now. Try again later.
Articles 1–20